Newron Pharmaceuticals S.p.A. (NP5.F)
Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
As of 11:47AM CEST. Market open.
| Previous Close | 10.30 |
| Open | 10.52 |
| Bid | 10.04 x 0 |
| Ask | 10.36 x 0 |
| Day's Range | 10.34 - 10.52 |
| 52 Week Range | 3.84 - 12.50 |
| Volume | |
| Avg. Volume | 1,175 |
| Market Cap | 199.622M |
| Beta (5Y Monthly) | 0.70 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.91 |
| Earnings Date | Mar 19, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
Business WireNewron Announces Positive Top-line Results From Potentially Pivotal Phase II/III Study 008A With Evenamide in Schizophrenia Patients
MILAN, April 30, 2024--Newron announces positive top-line results from potentially pivotal Phase II/III study 008A with evenamide in schizophrenia patients
Business WireData from Newron’s study 014/015 and an evenamide clinical development outlook presented at the 2024 Annual Congress of the Schizophrenia International Research Society (SIRS)
MILAN, April 08, 2024--Newron presents existing evenamide study 014/015 data and future clinical development outlook for evenamide at 2024 SIRS Congress in Florence, Italy
Business WireNewron Presents 2023 Financial Results and Provides 2024 Outlook
MILAN, March 19, 2024--Newron Pharmaceuticals announces 2023 year-end financial results and provides 2024 business outlook.
© 2024 Yahoo. All rights reserved.